课题基金 / 基金详情

Deciphering the role of the ASGR1/2 pathway in cardiometabolic disease

Deciphering the role of the ASGR1/2 pathway in cardiometabolic disease
解读 ASGR1/2 通路在心脏代谢疾病中的作用
批准号:
461769
负责人:
Austin Richard C
金额:
$54.06万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2022
资助国家:
加拿大
项目状态:
未结题
起止时间:
2022-03-01 至 2027-03-01

项目摘要

项目成果

Austin Richard C的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Cardiometabolic disease (CMD) consists of several modifiable risk factors such as diabetes, obesity and lipids that can lead to a heart attack or stroke and accounts for the majority of deaths in North America. CMD drives atherosclerosis, the underlying c
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
GRP78 as a driver and therapeutic target of atherothrombotic cardiovascular disease
  • 批准号:
    478355
  • 项目类别:
    Operating Grants
  • 资助金额:
    $58.52万
  • 财政年份:
    2023
  • 负责人:
    Austin Richard C
  • 依托单位:
GRP78 as a driver and therapeutic target of atherothrombotic cardiovascular disease
  • 批准号:
    477262
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2022
  • 负责人:
    Austin Richard C
  • 依托单位:
Retention of PCSK9 in the endoplasmic reticulum acts as a co-chaperone to protect against liver injury/dysfunction
  • 批准号:
    418859
  • 项目类别:
    Operating Grants
  • 资助金额:
    $50.44万
  • 财政年份:
    2020
  • 负责人:
    Austin Richard C
  • 依托单位:
Role of TDAG51 in vascular calcification associated with chronic renal disease
  • 批准号:
    344190
  • 项目类别:
    Operating Grants
  • 资助金额:
    $68.23万
  • 财政年份:
    2016
  • 负责人:
    Austin Richard C
  • 依托单位:
海外基金